RO60 and systemic lupus erythematosus: All pSS patients meet ACR/EULAR 2016 classification criteria and present anti-SSA/Ro60 antibodies, whereas all SLE patients were negative for anti-SSA/Ro60 antibodies and did not report sicca symptoms.